Home
About
Services
Partners
Client Portfolio
News
Contact
Coty appoints Chairman Peter Harf as CEO
June 1, 2020
Factbox: What’s new with the Fed’s 2020 bank stress tests?
June 1, 2020
0
Gilead trades that made millions on COVID-19 drug news raise eyebrows
Published by
Muller&Green
at
June 1, 2020
Categories
RSS
Tags
Well-timed trades in Gilead Sciences Inc’s options ahead of good news on the biopharmaceutical company’s COVID-19 drug treatment may draw regulatory scrutiny, experts said.
Powered by
WPeMatico
Muller&Green
Related posts
December 17, 2024
Five Lessons From My Mentor
Read more
December 13, 2024
Where Does Corporate Climate Action Go Next?
Read more
December 12, 2024
CEO of the Year Lisa Su Talks Competition and Collaboration in the Semiconductor Industry
Read more